Navigation Links
Cancer 'cure' in mice to be tested in humans
Date:6/28/2008

WINSTON-SALEM, N.C. Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.

The treatment will involve transfusing specific white blood cells, called granulocytes, from select donors, into patients with advanced forms of cancer. A similar treatment using white blood cells from cancer-resistant mice has previously been highly successful, curing 100 percent of lab mice afflicted with advanced malignancies.

Zheng Cui, Ph.D., lead researcher and associate professor of pathology, will be announcing the study June 28 at the Understanding Aging conference in Los Angeles.

The study, given the go-ahead by the U.S. Food and Drug Administration, will involve treating human cancer patients with white blood cells from healthy young people whose immune systems produce cells with high levels of cancer-fighting activity.

The basis of the study is the scientists' discovery, published five years ago, of a cancer-resistant mouse and their subsequent finding that white blood cells from that mouse and its offspring cured advanced cancers in ordinary laboratory mice. They have since identified similar cancer-killing activity in the white blood cells of some healthy humans.

"In mice, we've been able to eradicate even highly aggressive forms of malignancy with extremely large tumors," Cui said. "Hopefully, we will see the same results in humans. Our laboratory studies indicate that this cancer-fighting ability is even stronger in healthy humans."

The team has tested human cancer-fighting cells from healthy donors against human cervical, prostate and breast cancer cells in the laboratory with surprisingly good results. The scientists say the anti-tumor response primarily involves granulocytes of the innate immune system, a system known for fighting off infections.
'/>"/>

Contact: Jonnie Rohrer
jrohrer@wfubmc.edu
336-716-6972
Wake Forest University Baptist Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter
2. American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing
3. New clinical trial for patients with asbestos-associated lung cancer
4. Researchers identify promising cancer drug target in prostate tumors
5. CCNY researchers demonstrate effectiveness of contrast agent Cytate in detectcing prostate cancer
6. Ovarian cancers specific scent detected by dogs
7. Elevated biomarkers predict risk for prostate cancer recurrence
8. Faulty DNA repair could be a risk factor for lung cancer in nonsmokers
9. Breast Cancer Vaccines Look Promising
10. Pregnancy may help protect against bladder cancer
11. Hyundai Motor America and Its Dealers Launch National Hope on Wheels Tour to Support Pediatric Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... 21, 2014 AngelWeddingDress.com’s new collection of ... a total of 1,000 new designs in this collection, ... spring 2015. , AngelWeddingDress.com promises to provide ... with wardrobe essentials while many fashion trends come and ... customer service team at AngelWeddingDress.com is ready to assist. ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Recently, one ... world, LunaDress Prom Shop has introduced its ... Christmas Sale, offering big discounts on all its prom ... off. , LunaDress insists on providing top quality dress ... and it is considered as one of the best ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Serious Buyer, ... for Vintage 1967 Jm Morrison and the Doors International Ballroom ... This would also be the only time that Morrison's ... was on Nov. 25, 1967. According to Hawley, “This ... They did play the Alexandria Roller Rink earlier that ...
(Date:12/21/2014)... 2014 SCI explores disability ... and systemic barriers for disabled athletes with Aaron ... has a condition called juvenile macular degeneration, where he ... he adapted his athletic ambitions to his vision and ... triathlon to pioneer the way for other blind and ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 CannabisClassifieds.com celebrates marijuana’s ... The only one of its kind, the site has ... local marijuana for 14 years running. It uniquely combines ... to make cannabis readily available to the masses. Assuring ... grasping the golden ring of public approval. , ...
Breaking Medicine News(10 mins):Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2
... diet, researchers say , WEDNESDAY, July 8 (HealthDay News) -- ... common amino acids in vegetable protein seems to lower blood ... shows that a 4.72 percent higher intake of glutamic acid ... 1.5- to 3-point reduction in average systolic blood pressure (the ...
... 8 Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: ... non-invasive, topically administered products, today announced they have ... pivotal Phase 3 clinical study for Ketotransdel(R), a ... acute pain. , , Based on ...
... N.Y., July 8 The Max Cure Foundation -- a ... -- announced today its first charity benefit, the first annual ... take place on Saturday, August 22, from 2:00 - 6:00 ... the East Hampton Indoor Tennis Club, 175 Daniels Hole Road, ...
... July 8 Perot Systems Corporation (NYSE: ... an agreement with the Hunan Provincial Government of the ... to provide IT consulting services for healthcare organizations and ... the Provincial Government and in alignment with the Chinese ...
... ... High Definition videoconferencing, audiovisual (AV), networked solutions and services to offer video conferencing ... global room affiliates. , ... Denver, CO and Camarillo, CA (PRWEB) July 8 -- Affinity ...
... ... popularity. These parts washers are cost effective and quick solutions for companies that need ... ... Midbrook, a Jackson, MI based manufacturer of industrial parts washing systems, medical decontamination systems, ...
Cached Medicine News:Health News:Vegetable Amino Acid Lowers Blood Pressure 2Health News:Vegetable Amino Acid Lowers Blood Pressure 3Health News:Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment 2Health News:Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment 3Health News:The Max Cure Foundation Announces Its First Charity Benefit: The 'Roar for a Cure' Carnival to Be Held on Saturday, August 22, 2009 2Health News:The Max Cure Foundation Announces Its First Charity Benefit: The 'Roar for a Cure' Carnival to Be Held on Saturday, August 22, 2009 3Health News:The Max Cure Foundation Announces Its First Charity Benefit: The 'Roar for a Cure' Carnival to Be Held on Saturday, August 22, 2009 4Health News:The Max Cure Foundation Announces Its First Charity Benefit: The 'Roar for a Cure' Carnival to Be Held on Saturday, August 22, 2009 5Health News:Perot Systems Selected to Implement Health Information Systems in China 2Health News:Perot Systems Selected to Implement Health Information Systems in China 3Health News:Affinity VideoNet Partners With Providea Conferencing 2Health News:Affinity VideoNet Partners With Providea Conferencing 3Health News:Refurbished and Used Industrial Parts Washers Grow in Popularity 2
(Date:12/19/2014)... China separating membrane market has witnessed robust development ... years, albeit as a later starter. In 2012, the size ... approximated RMB12 billion, with the proportion worldwide soaring to 16.3%. ... membrane market will continue its growth rate by around 20% ... will jump to roughly RMB25 billion. An integrated ...
(Date:12/17/2014)... , Dec. 17, 2014  Northstar Global Business ... Trust Company (DTC) has made their final decision ... on the Company,s stock effective December 15, 2014, ... stock for depository and book entry transfer services. All ... is now once again fully "DTC Eligible", and ...
(Date:12/17/2014)...  IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or ... of $125 million aggregate principal amount of 3.75% Convertible ... offered and sold only to qualified institutional buyers pursuant ... as amended (the "Securities Act"). The Notes ... year, payable semiannually in arrears on June 15 and ...
Breaking Medicine Technology:Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... plc , (LSE: SHP, Nasdaq: SHPGY ), the ... and Drug Administration (FDA) approved the use of once-daily ... for the treatment of attention deficit hyperactivity disorder (ADHD) in ... a total treatment program. The approval is based on results ...
... YORK, Feb. 28, 2011 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... the Company,s Chief Executive Officer, will be presenting at ... Conference (New York, NY)Wednesday, March 2, 201111:00am ETCowen & ... MA)Monday, March 7, 2011 4:45pm ETROTH 23rd Annual OC ...
Cached Medicine Technology:FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 2FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 3FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 4FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 5FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 6Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: